These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 21867834)

  • 1. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
    Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
    J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
    Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database.
    Lee DS; Krahn AD; Healey JS; Birnie D; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    J Am Coll Cardiol; 2010 Feb; 55(8):774-82. PubMed ID: 20170816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.
    Hsu JC; Varosy PD; Parzynski CS; Chaudhry SI; Dewland TA; Curtis JP; Marcus GM
    Am Heart J; 2015 Jan; 169(1):45-52.e3. PubMed ID: 25497247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
    Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
    Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician procedure volume and complications of cardioverter-defibrillator implantation.
    Freeman JV; Wang Y; Curtis JP; Heidenreich PA; Hlatky MA
    Circulation; 2012 Jan; 125(1):57-64. PubMed ID: 22095828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation.
    Goldberger Z; Elbel B; McPherson CA; Paltiel AD; Lampert R
    J Am Coll Cardiol; 2005 Sep; 46(5):850-7. PubMed ID: 16139136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spanish implantable cardioverter-defibrillator registry. First official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2002-2004)].
    Peinado R; Arenal A; Arribas F; Torrecilla E; Alvarez M; Ormaetxe JM; Pérez-Castellano N
    Rev Esp Cardiol; 2005 Dec; 58(12):1435-49. PubMed ID: 16371203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-hospital complications associated with reoperations of implantable cardioverter defibrillators.
    Steckman DA; Varosy PD; Parzynski CS; Masoudi FA; Curtis JP; Sauer WH; Nguyen DT
    Am J Cardiol; 2014 Aug; 114(3):419-26. PubMed ID: 24927972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States.
    Tsai V; Goldstein MK; Hsia HH; Wang Y; Curtis J; Heidenreich PA;
    Circ Cardiovasc Qual Outcomes; 2011 Sep; 4(5):549-56. PubMed ID: 21878667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.
    Thijssen J; van den Akker van Marle ME; Borleffs CJ; van Rees JB; de Bie MK; van der Velde ET; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):25-34. PubMed ID: 23998638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR
    Gleva MJ; Wang Y; Curtis JP; Berul CI; Huddleston CB; Poole JE
    Am J Cardiol; 2017 Nov; 120(10):1891-1898. PubMed ID: 28917495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Cheng A; Wang Y; Curtis JP; Varosy PD
    J Am Coll Cardiol; 2010 Nov; 56(20):1651-6. PubMed ID: 21050975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.